Building on prior research by Gallo-Bernal et al. [12], we identified a 2.6-fold higher likelihood of developing kidney angiomyolipoma in patients with TSC2 mutation, reinforcing the role of TSC genotype as a predictor for kidney involvement [13]. The gene discussed is TSC2; the disease is kidney angiomyolipoma.